Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Historical redlining and neighborhood deprivation are associated with caregiver exclusion following evaluation for suspected child physical abuse: A multicenter study.

The journal of trauma and acute care surgery·2026
Same author

Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype.

Genome medicine·2025
Same author

Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics.

Blood·2025
Same author

Blood-Based T-Cell Diagnosis of Celiac Disease.

Gastroenterology·2025
Same author

Multiple Sclerosis Polygenic Risk Is Not Enriched in Three Multicase Families in Comparison to Population-Based Cases.

Human mutation·2025
Same author

Neuronal somatic mutations are increased in multiple sclerosis lesions.

Nature neuroscience·2025
Same journal

Abstracts from Specialized Centers of Research Excellence (SCORE) on Sex Differences 2025 annual meeting.

BMC proceedings·2026
Same journal

Conference abstracts the 1st UDOM scientific conference on health: healthy lives and well-being for all: opportunities and challenges.

BMC proceedings·2026
Same journal

Entrepreneurship beyond the lab: commercializing your creative outputs.

BMC proceedings·2026
Same journal

The need to strengthen laboratory leadership, systems, and networks to enhance outbreak detection and resilience in Africa: proceedings of a regional workshop.

BMC proceedings·2026
Same journal

Abstracts from the Globesync Community Research and Sustainability 2025 (GlobeCoReS 2025).

BMC proceedings·2026
Same journal

Bauru International Craniofacial Symposium: Comprehensive Care, Policy and Advocacy Proceedings.

BMC proceedings·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Resampling procedures to identify important SNPs using a consensus approach.

Christopher Pardy1, Allan Motyer, Susan Wilson

  • 1Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales 2052, Australia. cpardy@unsw.edu.au.

BMC Proceedings
|March 1, 2012
PubMed
Summary
This summary is machine-generated.

This study identifies common single-nucleotide polymorphisms (SNPs) that improve prediction accuracy beyond clinical variables. The algorithmic approach showed success for Q1 prediction but less for others, highlighting potential for genetic marker discovery.

More Related Videos

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Related Experiment Videos

Last Updated: May 24, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Area of Science:

  • Genetics and Bioinformatics
  • Statistical Genomics
  • Computational Biology

Background:

  • Identifying genetic variants that contribute to disease prediction is crucial for personalized medicine.
  • Clinical variables alone may not capture the full spectrum of predictive information for complex traits.
  • Common single-nucleotide polymorphisms (SNPs) with minor allele frequency > 1% are potential candidates for predictive modeling.

Purpose of the Study:

  • To identify common SNPs that enhance predictive accuracy beyond established clinical variables.
  • To develop and validate an algorithmic approach for predicting phenotypic variables using combined clinical and genotypic data.
  • To assess the performance of the proposed method across different simulated phenotypic outcomes.

Main Methods:

  • An algorithmic approach combining phenotypic and genotypic predictors was employed.
  • Random forests were used for initial feature selection, identifying approximately 100 important SNPs.
  • Least Absolute Shrinkage and Selection Operator (LASSO) with cross-validation was applied for further variable selection and shrinkage parameter tuning.

Main Results:

  • The proposed procedure demonstrated good performance in predicting the Q1 outcome.
  • Predictive accuracy for other outcomes was less successful, indicating outcome-specific performance.
  • Resampling procedures were utilized to mitigate false positives and enhance generalizability.

Conclusions:

  • The developed method effectively identifies SNPs that add predictive value, particularly for certain phenotypes.
  • The combination of random forests and LASSO provides a robust framework for SNP selection in predictive modeling.
  • Further investigation is needed to understand the limitations and improve performance for less predictable outcomes, especially concerning correlated false positives.